
	Mr. Steven McAllister, also known as Steve, has been an Interim Chief Financial Officer of InVivo Therapeutics Holdings Corp. since December 31, 2013. Mr. McAllister served as Vice President of Finance and Administration for Biomet Spine and Bone Healing Technologies from 2007 to 2013. From 1999 to 2007, he served in several capacities, including Director of Finance, Worldwide Operations for Depuy Inc. From 1984 to 1999, he worked in several capacities at Howmedica, a Pfizer subsidiary that was sold to Stryker in 1998. He has expertise in both finance and in the operations of device companies.
